Skip to main content
Signal8

Lecault Veronique

SEC insider (Form 3/4/5 filer). CIK 0001834418. Chief Technology Officer at AbCellera Biologics Inc. (ABCL). 2 reported Form 4/5 transactions since Sep 2024; latest on Jan 1, 2026. Located in VANCOUVER, A1.

Companies Lecault Veronique has filed insider reports for

  • AbCellera Biologics Inc. (ABCL): Director, Officer, Chief Technology Officer
Lecault Veronique profile photo

Lecault Veronique

CIK: 0001834418

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AbCellera Biologics Inc. logo
ABCL

AbCellera Biologics Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • AbCellera Biologics Inc. logo
    ABCL

    AbCellera Biologics Inc.

    Jan 1, 2026
    Award

    Share option (right to buy)

    Direct
    539.3K shares-
  • AbCellera Biologics Inc. logo
    ABCL

    AbCellera Biologics Inc.

    Jan 1, 2025
    Award

    Share option (right to buy)

    Direct
    832K shares-

1-2 of 2